
First Patient Dosed in Necrobiosis Lipoidica Clinical Trial
According to a story from sectorpublishingintelligence.co.uk, the biopharmaceutical company Processa Pharmaceuticals, Inc. recently announced that the first patient had been dosed in the company's Phase 2 clinical trial. This trial…